Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z7LK
|
||||
| Former ID |
DIB006476
|
||||
| Drug Name |
GSC-1
|
||||
| Synonyms |
Alpha-glucosidase inhibitor (hyperglycemia), Dharma Biomedical
|
||||
| Indication | Hyperglycemia [ICD9: 790.29; ICD10:R73.9] | Investigative | [1] | ||
| Company |
Dharma Biomedical
|
||||
| Target and Pathway | |||||
| Target(s) | Maltase-glucoamylase, intestinal | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Galactose metabolism | ||||
| Starch and sucrose metabolism | |||||
| Metabolic pathways | |||||
| Carbohydrate digestion and absorption | |||||
| PathWhiz Pathway | Starch and Sucrose Metabolism | ||||
| WikiPathways | Metabolism of carbohydrates | ||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2627). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.